1. Pulmonary function in diabetes mellitus

   • Michael David Goldman

   Invited Commentary Pages: 383 - 384

2. Web alert

   News Pages: 385 - 386

3. Literature alert

   Abstract Pages: 387 - 389

4. Clinical trials report

   • Anthony L. McCall

   BriefCommunication Pages: 393 - 395

5. Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes

   • Milagros G. Huerta
   • Jerry L. Nadler

   OriginalPaper Pages: 396 - 402

6. Insulin analogues: New therapies for type 2 diabetes mellitus

   • M. Angelyn Bethel
   • Mark N. Feinglos

   OriginalPaper Pages: 403 - 408

7. Antiobesity drugs: Current and future issues

   • M. Ammar Hatahet
   • Nikhil V. Dhurandhar

   OriginalPaper Pages: 409 - 415

8. Preventing diabetes by treating aspects of the metabolic syndrome

   • Roopa Sathyaprakash
   • Robert R. Henry

   OriginalPaper Pages: 416 - 422

9. The choice of antihypertensive drugs in patients with diabetes: Angiotensin II and beyond

   • Kambiz Kalantarinia
   • Helmy M. Siragy

   OriginalPaper Pages: 423 - 430

10. Fitness decreases risk of all-cause and cardiovascular disease mortality whereas thinness does not

    • Marion J. Franz

    Clinical Trials Report Pages: 433 - 434

11. The influence of dietary fat on insulin resistance

    • Jennifer C. Lovejoy

    OriginalPaper Pages: 435 - 440

12. Cardiovascular fitness and type 2 diabetes

    • Cathy Mullooly

    OriginalPaper Pages: 441 - 447

13. Antioxidant vitamins and their influence in diabetes mellitus

    • Bibi Hasanain
    • Arshag D. Mooradian

    OriginalPaper Pages: 448 - 456

14. Protein and diabetes: Much advice, little research

    • Marion J. Franz

    OriginalPaper Pages: 457 - 464